NewsAssessing Tumor Progression in Neuroendocrine Cancer PatientsThermo Fisher ScientificThermo Fisher announces FDA-clearance of first-to-market automated assay
NewsPhase 3 Trial for Neuroendocrine Tumor Treatment Shows PromiseThe Alliance for Clinical Trials in OncologyThe safety profile of cabozantinib observed in the trial was consistent with its known safety profile
NewsNeuroendocrine Tumors: Choosing the Best TreatmentUniversity of GenevaWhich treatments for which patient?